Any current/future new fundraising through debt or equity?

Currently, Laxmi Dental Limited has a strong balance sheet with a very low debt-to-equity ratio of 0.06. The company has about INR100 crores of cash on the books and expects to generate another INR100-120 crores over the next 2 years, totaling around INR200-220 crores cash. There is no explicit mention of any immediate plans for new fundraising through debt or equity. The company plans to use existing cash for a planned capex of around INR68 crores and may increase capex based on growth visibility. Management is open to inorganic growth opportunities but will evaluate them carefully; no specif

Any current/future capex/capital investment/strategic investment?

Current planned capex is close to INR 68 crores from IPO proceeds, with only a small amount spent in FY25; major deployment happening in the current financial year. The company is investing in cutting-edge equipment identified at the IDS dental show in Germany, including intraoral scanners and machinery, with orders placed. Focus is on increasing digital penetration (currently at 64%, up from 49%), aiming for 90-95% digitization, especially for lab and aligner categories. Evaluating inorganic growth opportunities that offer synergy and can support future growth, while maintaining frugality. Po

Future growth expectations in sales/revenue/volumes?

Laxmi Dental aims to sustain a strong revenue CAGR of 20%-25% over the next 2-3 years, building on FY25’s 23.5% growth. The company is bullish on achieving even stronger growth than last year’s 24% growth rate. Growth will be volume-driven, especially in the aligner segment, with minimal price hikes. Digitization and automation efforts are expected to enhance operational efficiency and scale volumes. Expansion plans include increasing wallet share with existing dental partners, adding new dentists, and expanding geographic reach. Investments in new technologies and equipment (e.g., intraoral s

Future growth expectations in earnings/operating earnings/profits/EPS?

Laxmi Dental is bullish on achieving stronger growth than the 24% CAGR reported in the last year, targeting a 20%-25% revenue CAGR going forward. EBITDA margins were around 18% reported (21% adjusted for ESOPs), with confident expectations for margin expansion through increased digitization and automation. Ongoing digitization aims to eliminate 25%-30% of processes, enhancing operational efficiency and reducing costs. Aligners business is volume-driven with minimal price hikes, indicating scalable growth potential. Capex of around INR68 crores planned from IPO proceeds with potential f

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders for Laxmi Dental Limited. However, the company has indicated confidence in continued growth and increasing demand, particularly in the aligner and laboratory businesses. Digitization and automation efforts are underway to improve operational efficiency and capacity utilization. The management is optimistic about expanding capacity driven by regulatory clearances and market tailwinds. They are also exploring inorganic growth opportunities to leverage future expansion. Growing production volumes sugge

Laxmi Dental LtdQ4 FY25Healthcare Equipment & Supplies

Laxmi Dental Ltd Q4 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹185P/E: 29.2Market Cap: ₹1.0K CrSector: Healthcare Equipment & Supplies

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

N/A

Order

N/A

Capex

Yes

2 of 3 growth signals are positive.

Full analysis

Revenue guidance

Category 2

Laxmi Dental aims to sustain a strong revenue CAGR of 20%-25% over the next 2-3 years, building on FY25’s 23.5% growth.
The company is bullish on achieving even stronger growth than last year’s 24% growth rate.
Growth will be volume-driven, especially in the aligner segment, with minimal price hikes.
Digitization and automation efforts are expected to enhance operational efficiency and scale volumes.
Expansion plans include increasing wallet share with existing dental partners, adding new dentists, and expanding geographic reach.
Investments in new technologies and equipment (e.g., intraoral scanners) post-IDS dental show will support growth.
Inorganic growth opportunities with strong synergy potential are being evaluated.
International business, especially US exports, is showing strong traction and will contribute to future growth.

Margin guidance

Category 1

Laxmi Dental is bullish on achieving stronger growth than the 24% CAGR reported in the last year, targeting a 20%-25% revenue CAGR going forward.
EBITDA margins were around 18% reported (21% adjusted for ESOPs), with confident expectations for margin expansion through increased digitization and automation.
Ongoing digitization aims to eliminate 25%-30% of processes, enhancing operational efficiency and reducing costs.
Aligners business is volume-driven with minimal price hikes, indicating scalable growth potential.
Capex of around INR68 crores planned from IPO proceeds with potential for increases based on growth visibility.
ESOP expenses of INR14 crores spread over 4 years will impact P&L.
Management is optimistic on sustained EBITDA margin expansion over the next 2-3 years with deployment of capital and technology improvements.
International business, especially in the US, is expected to contribute strongly despite global tariff challenges.

See what Laxmi Dental Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Currently, Laxmi Dental Limited has a strong balance sheet with a very low debt-to-equity ratio of 0.06.
The company has about INR100 crores of cash on the books and expects to generate another INR100-120 crores over the next 2 years, totaling around INR200-220 crores cash.
There is no explicit mention of any immediate plans for new fundraising through debt or equity.
The company plans to use existing cash for a planned capex of around INR68 crores and may increase capex based on growth visibility.
Management is open to inorganic growth opportunities but will evaluate them carefully; no specific fundraising tied to this was stated.
Focus remains on deploying current resources toward digitization, automation, and operational efficiency rather than raising fresh capital.

Order book

The transcript does not explicitly mention the current or expected order book or pending orders for Laxmi Dental Limited.
However, the company has indicated confidence in continued growth and increasing demand, particularly in the aligner and laboratory businesses.
Digitization and automation efforts are underway to improve operational efficiency and capacity utilization.
The management is optimistic about expanding capacity driven by regulatory clearances and market tailwinds.
They are also exploring inorganic growth opportunities to leverage future expansion.
Growing production volumes suggest a growing backlog of orders, but no specific figures are disclosed in the transcript.

See what Laxmi Dental Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Current planned capex is close to INR 68 crores from IPO proceeds, with only a small amount spent in FY25; major deployment happening in the current financial year.
The company is investing in cutting-edge equipment identified at the IDS dental show in Germany, including intraoral scanners and machinery, with orders placed.
Focus is on increasing digital penetration (currently at 64%, up from 49%), aiming for 90-95% digitization, especially for lab and aligner categories.
Evaluating inorganic growth opportunities that offer synergy and can support future growth, while maintaining frugality.
Post IPO, the company has capital and capabilities to accelerate its growth and expand digital and geographic reach.
Emphasis on strategic investment in AI applications to enhance productivity and customer/dentist experience.

Track Laxmi Dental Ltd — get its next earnings analysis in your feed

How does Laxmi Dental Ltd rank vs peers in Healthcare Equipment & Supplies?

Pro feature

ThisLaxmi Dental Ltd

Rev 2Mar 1

See where Laxmi Dental Ltd sits in Healthcare Equipment & SuppliesSee which companies these are, and every other name in the sector.Open rankings

How does Laxmi Dental Ltd rank in Healthcare Equipment & Supplies?

Compare Laxmi Dental Ltd against every Healthcare Equipment & Supplies company (Q4 FY25) on revenue, margins and earnings-call signals.

View Healthcare Equipment & Supplies leaderboard →

What Laxmi Dental Ltd's management said in earlier quarters

Others in Healthcare Equipment & Supplies this season

QMS Medical Allied Services Ltd (Q3 FY26)
Q3FY26 Revenue from Operations: ₹37.3 crore . Key investor presentation takeaways from QMS Medical Allied Services Ltd's Q3 FY26 investor presentation — and how
Avience Biomedicals Ltd (Q1 FY27)
New manufacturing facility has capacity to support peak revenue of around ₹250–265 crore, subject to product mix and approvals. Key concall takeaways from…
Fischer Medical Ventures Ltd (Q2 FY25)
EBITDA: ₹36.3 crore, a 45.5% year-on-year increase. Key concall takeaways from Fischer Medical Ventures Ltd's Q2 FY25 earnings call — and how it ranks against…
Fischer Medical Ventures Ltd (Q1 FY27)
The provided pages of the investor presentation do not contain any specific revenue, sales, or volume figures for the quarter, nor details on year-on-year…

Compare:vs Molbio Diagnosti vs Fischer Medical Ventures Ltd vs Tarsons Products Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →